PUMA BIOTECHNOLOGY INC (PBYI) Stock Analyst Ratings
USA - NASDAQ:PBYI - US74587V1070 - Common Stock
5.99 USD
+1.09 (+22.24%)
6.01 USD
+0.02 (+0.33%)
ChartMill assigns a Buy % Consensus number of 43% to PBYI. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 4.42. This target is -26.21% below the current price.
PBYI was analyzed by 7 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about PBYI.
In the previous month the buy percentage consensus was at a similar level.
PBYI was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-02-28 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-23 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-20 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-02 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-07-26 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-06-04 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-06-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-20 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-01 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-02-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-09-20 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-04 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-06-05 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-05 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-03-06 | HC Wainwright & Co. | Reiterate | Buy |
| 2022-08-05 | HC Wainwright & Co. | Maintains | Buy |
| 2022-05-06 | HC Wainwright & Co. | Maintains | Buy |
| 2021-09-28 | Citigroup | Upgrade | Neutral -> Buy |
| 2021-08-06 | RBC Capital | Maintains | Sector Perform |
| 2021-08-06 | Goldman Sachs | Maintains | Sell |
PUMA BIOTECHNOLOGY INC / PBYI FAQ
What do analysts expect the price target to be for PUMA BIOTECHNOLOGY INC (PBYI)?
7 analysts have analysed PBYI and the average price target is 4.42 USD. This implies a price decrease of -26.21% is expected in the next year compared to the current price of 5.99.
Can you provide the consensus rating for PUMA BIOTECHNOLOGY INC stock?
The consensus rating for PUMA BIOTECHNOLOGY INC (PBYI) is 42.8571 / 100 . This indicates that analysts generally have a neutral outlook on the stock.
Can you provide the analyst count for PUMA BIOTECHNOLOGY INC stock?
The number of analysts covering PUMA BIOTECHNOLOGY INC (PBYI) is 7.